Stephen Bloch is the founder of EvolveImmune Therapeutics. EvolveImmune Therapeutics has raised $35M in total funding. Latest round: Series A.
Stephen Bloch, MD, is a veteran Connecticut venture capitalist who co-founded and currently serves as the CEO of EvolveImmune Therapeutics. His company focuses on using CRISPR gene-editing technology for developing drugs to treat cancer and autoimmune diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library